Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert J. Motzer
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy
New England Journal of Medicine
Medicine
Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination With Bevacizumab Versus Sunitinib in Renal Cell Carcinoma
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Clinical and Pathologic Impact of Select Chromatin-Modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
European Urology
Urology
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer - Data From a Randomized Phase III Trial
Cancer Discovery
Oncology
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
Phase 1 Trials of Anti-Enpp3 Antibody Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
Clinical Cancer Research
Cancer Research
Oncology
Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Clinical Cancer Research
Cancer Research
Oncology
Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients With Advanced Renal Cell Carcinoma
European Journal of Cancer
Cancer Research
Oncology
Mp71-10 Clinical Features of Recurrent Somatic Mutations in Clear Cell Renal Cell Carcinoma: A Large Cohort
Journal of Urology
Urology
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib
Oncology
Medicine
Cancer Research
Oncology
1
2
›
